|
Jun 2026
As of Jun 30, 2026
|
Mar 2026
As of Mar 31, 2026
|
|
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash equivalents | ||
| Due from Sponsor | ||
| Prepaid expenses | ||
| Total current assets | ||
| Deferred offering costs | ||
| Investments held in Trust Account | ||
| Total Assets | ||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | ||
| Accrued offering costs | ||
| Accrued expenses | ||
| Promissory note – related party | ||
| Total current liabilities | ||
| Deferred consulting fees | ||
| Deferred legal fees | ||
| Deferred underwriting fee | ||
| Total Liabilities | ||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 21,461,600 shares at redemption value of $10.13 per share | ||
| Shareholders’ Deficit | ||
| Ordinary shares, share value | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Additional paid-in capital | ||
| Accumulated deficit | ||
| Total Shareholders’ Deficit | ||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
